First human trial tests new Drug's safety
NCT ID NCT06286033
Summary
This was an early-stage study to check the safety and see how the body processes a new drug called AG-181. It involved 88 healthy volunteers who took either the drug or a placebo. The main goal was to see if the drug was safe and to measure how much of it got into the bloodstream, both with and without food.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON 1255 East 3900 South
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.